Cost-effectiveness of mepolizumab for severe eosinophilic asthma in China. Chaogang X, Mengna A, Zhen W, Ying L, et al. J Asthma 2024 Mar 12:1-8. doi: 10.1080/02770903.2024.2324855.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chaogang X, Mengna A, Zhen W, Ying L, et al. Cost-effectiveness of mepolizumab for severe eosinophilic asthma in China. J Asthma 2024 Mar 12:1-8. doi: 10.1080/02770903.2024.2324855.
PMID: 38470879